chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was discovered that children under the age of 5 are not eligible for a booster of a different brand.  Thais patient had 3 pfizer vaccines for the initial series and received a modena bivalent booster.
I started hearing a humming in my ears two weeks after my first dose.  At first it would come and go and I didn?t pay much attention to it. I had my second dose on March 24th and now the humming is pretty constant.  That dose was lot 007821A
This spontaneous report was received from a medical assistant (also reported as a healthcare worker) concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. On an unknown date, after receiving ZOSTAVAX, the patient experienced an unspecified reaction. The patient sought medical attention (office visit). The outcome of unspecified reaction was unknown. The reporter enquired on behalf of the physician regarding the ingredients in ZOSTAVAX of it has neomycin and formaldehyde. The relatedness for the unspecified reaction was unknown for ZOSTAVAX. Additional information has been requested.
Pt presented to the local ER on 10/30/09 with fever and irritability. Work-up revealed aseptic meningitis. 12/29/09 DC summary and MR received for dates 10/31/09 to 11/3/09. DX: aseptic meningitis. SX: fever, irritable. Parent states pt was vaccinated recently.
exaggerated startle reflex, each lasting approximately 1 second, sets of 5-15, 5-15 sets/day (diagnosed with infantile spasms)
This was a Booster/3rd shot. I had Pfizer 4/14/21 and 5/5/21.  I was on NSAID's everyday except one (noted below) = no fever, but could be masked  Monday 11/22 Moderna covid booster left arm Normal Exercise tolerance ? weight lift and elliptical and walk Weight ~156  Tuesday 11/23 3-4+ pound weight gain - Weight 160 Normal Exercise tolerance ? weight lift and elliptical and walk  Wednesday 11/24 3-4+ pound weight gain - Weight 163 Pitting Edema in legs 1-2+ Heart palpitations  General Fatigue Went to Doctor and DXTCs done Normal Exercise tolerance ? weight lift Increased sleep - three +hours     Evening  Difficulty breathing  Mild chest tightness/pain Shortness of breath Change in cough quality - harder Heart palpitations - bedtime   Thursday 11/25 Difficulty rousing in AM Increased pitting Edema 2-3+  -above my knees, arms and face Exercise intolerance ? Pretty much normal work out am wt lift, afternoon: got on elliptical - slow pace, felt better, reduced headache &BP, evening - walk Heart palpitations - bedtime  Friday 11/26 Trippy nightmares  Difficulty rousing in AM Dizziness/Floaty all day Felt BAD all day Edema easing - 1-2+  Lost 3 pound water weight  Hi blood pressure episodes (160-140?s/upper 80-90?s) with Moderate to Severe headache  Extreme fatigue - <2K steps all day, Exercise intolerance +++ - No exercise at all! Inappetence Excessive sleep ? 12 hours at night plus 3 hour nap = 15+ hours Mild chest tightness Mild chest soreness Heart palpitations - bedtime, increased mildly  Saturday 11/27 Continued headaches with shorter episodes of high blood pressure chest tightness Increased chest soreness -  like a band around my chest radiate into my back and left neck 1+ Edema - Lost 3 pound water weight - wt 160 Elliptical ? chest pain moves, doesn?t feel good Moderate headache Heart palpitations - bedtime Inappetance Went to ER  Sunday 11/28 Reduced edema 1+ - Lost 3 # - Weight 157 Chest non-painful, not tight,  Reduced fatigue but still present Mild in appetence  Mild to moderate headache Temp 99.0 - Had stopped NSAID's temporarily  Monday 11/29 Barely discernable edema Most signs reduce low end  Weight 158 Headache with higher BP's BP lower - but high for me (130?s-120?s)
I experienced mouth sores, light headiness, dizziness and inflamed gums after my vaccine.   I went to an urgent care to seek treatment.
This spontaneous report as received from a registered nurse reporting that at her office immunocompetent patients were revaccinated with PNEUMOVAX 23 (doses and lot numbers not reported) every 5 years. The numbers of patients involved were unspecified. There were no symptoms reported. Additional information has been requested.
Initial unsolicited report received from a nurse on 27-SEP-2016. This case involves 60 patients (gender not reported) who were vaccinated with a dose of FLUZONE ID (batch number: UT5570AA, expiration date: 27-MAR-2017) intradermally in deltoid on 26-SEP-2016. Reporter denied patients Illness at time of vaccination and Pre-existing physician diagnosed allergies, birth defects, medical conditions was not reported. Concomitant medications were not reported. On 27-SEP-2016, one day following the vaccination, the patients had redness and swelling at the site and some claimed knot formation. Patients did not require physician evaluation as per reporter. Lab data was not reported and patients were advised to take Benadryl as corrective treatment. The outcome of the events was reported as unknown. List of documents held by sender: none.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. No medical history was reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiry, dose, route not reported). No concomitant medications were reported. On an unknown date, the patient experienced pain and tenderness at the injection site that appeared as a half moon mark, left visible on the upper arm. No treatment was received. No medical attention was sought by the patient. The outcome of pain and tenderness at the injection site was reported as recovered. Additional information is not expected.
Symptoms consistent with rotator cuff tendinitis postvaccination adverse effect that started 24-48 hrs. after the administration of both vaccines, influenza on lt deltoid and hepatitis B on the right one. Patient reached out to us on 10/7/22, her symptoms were triaged by one of our RNs, and was adviced to be seen in Urgent Care. So she did. Provider seeing patient at Urgent care stated this as the diagnosis: DIAGNOSIS: (M79.601,  M79.602) Bilateral arm pain  (primary encounter diagnosis) Comment: post vaccination pain- normal exam, range of movement, no signs or symptoms of infection Today, October 20, 2022, patient was seen by one of our Physician Assistants. This was her assessment:  Assessment & Plan (T50.Z95A) Vaccines and biological substances causing adverse effect in therapeutic use, initial encounter  (primary encounter diagnosis) (M79.601,  M79.602) Bilateral arm pain.  Plan: METHOCARBAMOL 500 MG PO TABS - Take one Tab by mouth at         bedtime as needed       NAPROXEN 500 MG PO TABS - Take one Tab by mouth twice daily         as needed
Presented with chest pain on April 15, 2021, was evaluated in the ER, and discharged home.  Presented again on April 18, 2021, and at that time chest pain is more persistent, therefore patient was admitted.  Had serial enzymes performed and was discharged the following day to follow-up with cardiology.   Unknown further outcomes beyond this.
Extreme chills and ultra hypersensitive skin. Extreme lethargy and pain in arm. I bundled up in many layers and laid in bed with the house thermostat set to 72. Chills and sensitivity have not abated in the 2 hours since onset.
extreme fatigue to a point last night she could not go to bed; diarrhea; tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue to a point last night she could not go to bed), DIARRHOEA (diarrhea) and COVID-19 (tested positive for covid-19) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (extreme fatigue to a point last night she could not go to bed) (seriousness criterion hospitalization), DIARRHOEA (diarrhea) (seriousness criterion hospitalization) and COVID-19 (tested positive for covid-19) (seriousness criterion hospitalization). At the time of the report, FATIGUE (extreme fatigue to a point last night she could not go to bed), DIARRHOEA (diarrhea) and COVID-19 (tested positive for covid-19) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case concerns an 82 Y/O F hospitalized with serious unexpected events of diarrhea, fatigue, and SARS-CoV-2 test positive. Event onset with unknown latency after first dose mRNA-1273. Treated with bamlanivimab. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an 82 Y/O F hospitalized with serious unexpected events of diarrhea, fatigue, and SARS-CoV-2 test positive. Event onset with unknown latency after first dose mRNA-1273. Treated with bamlanivimab. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
After 72 hours, lymph gland swelling under left arm (arm received injection in), sometimes radiating to neck and side or down to hand. Pain: 5/10. As of 3/30/21, no improvement in this symptom. Fatigue and mild nausea as well.
On 04/06 at 2pm, the pt developed high fever, redness and induration at injection site along with headache, neck pain and stomach crampin. On 04/07 at 2am, charley hoise in lower part of both legs, and softened stool. As morning progressed, stomach cramping became more severe with diarrhea. At 10am, passed out for unknown amount of tiem. Treated with codeine and Motrin.
pt c/o pain in lt arm p/vax;27MAR in PM had undocumented temp & was irritable;lt arm w/redness & swelling around site of inj & by 28MAR getting worse;pt unable to lift or raise arm d/t pain;seen in office 28MAR induration, pain chest
Patient had severe pain in one leg since 03/14/2021 Went to the emergency room on 03/21/2021 where he was notified that he had a clot in his lung. It caused a bilateral pulmonary embolism.
This spontaneous report was received from a pharmacist and refers to a 71-year-old female patient. The patient's concurrent conditions included asthma, hypertension and hypercholesterolaemia. She did not have any drug reactions or allergies. On 27-NOV-2013, the patient was vaccinated with one dose of ZOSTAVAX subcutaneous injection (lot # J006153, expiration date 30-AUG-2014), for prophylaxis. Then, on 17-MAY-2017, the patient received a second dose of ZOSTAVAX subcutaneous injection (lot # M038863, expiration date 12-DEC-2017), reconstituted with a sterile diluent (STERILE DILUENT) subcutaneous injection (dose, lot number and expiration date were not reported), for the same indication. Concomitant therapies included alprazolam (XANAX) and unspecified medications for hypertension, asthma and hypercholesterolaemia. On 17-MAR-2017 (also reported as on an unknown date), after the patient received the second dose of ZOSTAVAX, she experienced itching at the injection site, lasting for an unknown duration of time. No treatment was given for this. The patient did not seek medical attention or had any lab diagnostic studies performed. The outcome of itching at the injection site was unknown by the reporter. The relatedness between the event and therapy with ZOSTAVAX was not reported. Additional information has been requested.
Fever, headache, full body aches, muscle and joint. Onset 12 hours post-vaccination. Lasted approximately 12 hours. Took 2 Advil to alleviate symptoms.
Within 10 mins I had swelling, tingling and some numbness in my face and neck. I was checked by EMS at the site. Waited another 20 mins and the symptoms did not get worse or rapidly improve. I had a prescheduled doctor appointment and went directly to the doctor's office after the vaccine. Dr. confirmed that I had swelling and redness in my face and prescribed Methylpredsisolone 4mg 21 pack of steriods to take. That medication removed the symptoms.  On 02/01/21, 24 hrs after the last dose of the pack, the face swelling and tingling returned. As recommended I took Benedryl 2 tablets / 3 doses. I returned to Doctor's office on Tues 02/02 where she prescribed Presnisone 20mg for 5 days after seeing the swelling in my face and she said my lymph nodes were swollen as well.
Employee was approximately 4 weeks pregnant at the time of immunization.  Did not realize patient was pregnant at the time until reviewing records and then checking with patient for when she got pregnant.  She said she realized it later, but did not report it back to employee health nurse.  Employee has been advised to alert her OB provider.
Patient started to feel anxious and had increased respirations, lightheadedness, weakness, and looked pale. Patient was advised to take slow deep breaths and water was provided. Vitals signs taken: HR 84 and BP 140/60. After a few minutes, patient began to feel better. Mom was present the entire time. Patient left clinic without further incident.
The pfizer vial had sat at room temperature for 23 hours (the vial used the day before was left out and mistakenly used as the vial for the following day). The prescribing information allows only 12 hours at room temperature after puncture. I contacted Pfizer to obtain more information about stability and they informed me of a 12 hour excursion period after that initial 12 hour period post-puncture (i.e. stability at room temperature for 24 hours allowed). I notified the patient of this mishandling and informed him I would document it.
sore upper arm for 24-36 hours after injection; pregnant at 35 weeks at the time of vaccination; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, in the right arm, on 09Mar2021 09:15 (Lot number: EL9264), at age 32 years old, as dose 1, single, for COVID-19 immunisation, at a school/student health clinic. Relevant medical history and concomitant medications were not reported. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) for immunisaiton on 24Feb2021; sertraline, loratadine (CLARITIN) and an unspecified prenatal vitamin all for unknown indications, start and stop dates not reported. The patient was pregnant at 35 weeks at the time of vaccination. The pregnancy due date was reported as 12Apr2021. On 09Mar2021 at 12:00, the patient had sore upper arm for 24-36 hours after injection. No treatment was given for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19 via nasal swab in 2021 with negative result. The patient recovered from sore upper arm for 24-36 hours after injection in Mar2021.
Started getting up to walk out and patient said he was dizzy. He said he felt nauseous as he was walking out to get in the car. It lasted for about 1 1/2 hours.
hot, red, itchy rash from the injection site to top of her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot, red, itchy rash from the injection site to top of her shoulder/hotness), VACCINATION SITE PRURITUS (hot, red, itchy rash from the injection site to top of her shoulder) and VACCINATION SITE RASH (hot, red, itchy rash from the injection site to top of her shoulder) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot, red, itchy rash from the injection site to top of her shoulder/hotness), VACCINATION SITE PRURITUS (hot, red, itchy rash from the injection site to top of her shoulder) and VACCINATION SITE RASH (hot, red, itchy rash from the injection site to top of her shoulder). At the time of the report, VACCINATION SITE WARMTH (hot, red, itchy rash from the injection site to top of her shoulder/hotness) outcome was unknown and VACCINATION SITE PRURITUS (hot, red, itchy rash from the injection site to top of her shoulder) and VACCINATION SITE RASH (hot, red, itchy rash from the injection site to top of her shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. The patient was taking allergy medicine as a corrective treatment.    Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up received which contained no new information
Very bad headache 48 hrs. after vaccination; fever; chills; headache was all day, all night; no appetite; both legs were weak and walking was unsteady; fell once; could not walk at all need physical therapy and occupational therapy.
June 25,2021  I developed severe left sided neck pain that radiating into my left shoulder and left arm.   Then I woke up with left arm weakness on July 10,2021 that progressed to near loss of use of my left arm. I went to the ER on July 11, 2021 and I was diagnosed with Parsonage-Turner Syndrome. I had no preceding illness, no injury and I have tested negative to all autoimmune disorders.
fatigue, headache, body aches, fever up to 100.5 while taking tylenol every 3-4 hours. Fever lasts ~ 28 hours Symptoms resolved 48 hours post injection
She felt. Ad the evening of her 2nd vaccine.  The morning after she felt worse.  Nauseous, pale, achy. She said she had not ever felt that bad. I read possible side effects.  It said flu  like symptoms, so we thought it would pass.  Then around 4 she called for me & when I got there she had an event that caused her to be unable to speak & her eyes widened & pupils were dilated.  I called 911. They got here quick.  She had at least three of those stiffening wide eyed events.  The emt said they thought it was her blood sugar.  When checked it was 350 even though she had taken her insulin that day.  They said she had a massive heart attack on the way to the hospital.
16OCT95 noted pox-like lesions scattered;neck face, trunk & hip-12 only @ first;very itchy some moist-some like mosquito bites;resolved in about 24hrs; had new ones on 17OCT & 18OCT;23OCT95 reports all gone-about 20 spots total
This spontaneous report was received from a nurse practitioner referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 03-SEP-2016, the patient was vaccinated with improperly stored GARDASIL 9 lot # M007764, expiry date: 30-JAN-2018 (strength, dose number, route and anatomical location were not provided). Concomitant therapies were not provided. This is one of the several reports received from the same reporter. Additional information has been requested.
Called to scene, 2 staff members, including obs RN assisting pt - pt unconscious upon arrival, pale, cool, clammy skin, pupils dilated, HRR, regular RR. Assisted staff to lay patient supine on floor. Pt still unconscious, but no other changes. In less than 2 minutes supine, pt with sudden change in consciousness - face red, muscles tense, jerked away. Appeared seizure-like momentarily, RR called. Pt then resumed consciousness, confused initially, but then awareness resumed as RR team arrived. 911 also called by another staff member. VSS - BP 121/71, HR 58, SpO2 99%. Stable once sitting upright. RR team assessed, paramedics on scene. Determine pt stable and able to dismiss teams without further intervention. Pt stayed in observation for an additional 40 minutes until recovered. Had one bout of emesis, but reported feeling better after. Given Gatorade and snacks to consume once nausea improved. Escorted to first floor where pt had friends waiting. Encouraged to rest and rehydrate until fully recovered.
Started to feel unwell on 10/19/23 with shortness of breath. Progressively worsened with ER visit on 10/30/23 with diagnosed bilateral pulmonary embolisms, no DVT noted in lower legs. Elevated D Dimer 4000. Admit for observation to start Eliquis.
NO ADVERSE EVENT IS KNOWN AT THIS TIME. PURPOSE OF REPORT IS THAT PATIENT IS NOT 18 YEARS OF AGE AS REQUIRED BY MODERNA VACCINE
Information has been received from a health care professional concerning a female patient was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that the patient did not seroconvert. It was noted that at the time of the report the patient had not recovered. No other information was provided.
stroke like symptoms; stated that her voice has not come back from the day that she took the shot; has pins and needles in right leg; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: SC3182), via an unspecified route of administration, administered in right arm on 03Aug2021 (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she had a very bad reaction to the vaccine. On 03Sep2021, the patient experienced stroke-like symptoms and her voice has not came back from day that she took the first shot. She also had lasting effects of pins and needles in her right leg. She was hospitalized for 24 hours from 04Sep2021 to 05Sep2021. The patient also stated that she went to the emergency room for treatment of all symptoms. Outcome of the event stroke-like symptoms was recovered with sequel on 07Sep2021, voice has not come back was recovering, and pins and needles in leg was not recovered.
Vaccine given after it expired. Packing slip showed expiration of 12/31/2069.
pt nearly fainted-no loc,sweating, bp dropped aprox 5-10 min after vac.
throbbing pain from injection site to ring finger; Injection site soreness; Congestion; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 07Mar2021 at 08.30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levocetirizine dihydrochloride (XYZAL) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no known allergy to medication, food or other products. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 14Feb2021 at 08:30 as a single dose for COVID-19 immunisation. On 07Mar2021 at 12:00, the patient experienced injection site soreness, congestion, throbbing pain from injection site to ring finger. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site soreness, congestion, throbbing pain from injection site to ring finger were recovering at the time of report.   No follow-up attempts are possible. No further information is expected.
Arm redness-giant circle on arm. Numbness, tingling difficulty breathing, muscle weakness, difficulty walking: 2 days after shot. Lasted for 24 hours. 3 days later had laryngitis for 5 days. Fatigue continues.